2000
DOI: 10.25030/ncs-013
|View full text |Cite
|
Sign up to set email alerts
|

NCS Report 13: Quality control in brachytherapy: Current practice and minimum requirements

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
1

Year Published

2001
2001
2022
2022

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 0 publications
0
2
0
1
Order By: Relevance
“…TPSs should be compatible with these generic models and facilitate the MBDCA commissioning by implementing the tools necessary to perform an in-depth comparison of the 3D dose distributions. Finally, TPSs must easily perform the quality control tests suggested in the guidelines [ 29 , 30 , 31 ].…”
Section: Methodsmentioning
confidence: 99%
“…TPSs should be compatible with these generic models and facilitate the MBDCA commissioning by implementing the tools necessary to perform an in-depth comparison of the 3D dose distributions. Finally, TPSs must easily perform the quality control tests suggested in the guidelines [ 29 , 30 , 31 ].…”
Section: Methodsmentioning
confidence: 99%
“…NCS Report 7 [2] dealt with the calibration of high dose rate (HDR) sources. NCS Report 13 [3] gave general recommendations on the quality control (QC) of brachytherapy equipment.…”
Section: Introductionmentioning
confidence: 99%
“…Doch oft lassen sich die veröffent-lichten Daten nicht vergleichen oder gemeinsam auswerten [39,40], da verschiedene Dosisgrößen und sehr unterschiedliche Methoden der Dosisspezifikation verwendet wurden. Zur Optimierung der intravaskulären Brachytherapie sind daher einheitliche Methoden der Dosisverordnung, der Protokollierung und des strahlentherapeutischen Berichts [28,34,38] sowie standardisierte Methoden der Strahlerkalibrierung und der dosimetrischen Qualitätssicherung [15,28,38] erforderlich.…”
Section: Introductionunclassified